Mondelez (MDLZ, $52.06 ) beats Q1 earnings estimates

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MDLZ moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 20 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 49%.

The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MDLZ as a result. In 53 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 52%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDLZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for MDLZ just turned positive on October 08, 2026. Looking at past instances where MDLZ's MACD turned positive, the stock continued to rise in 27 of 44 cases over the following month. The odds of a continued upward trend are 61%.

MDLZ moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MDLZ crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.

Following a +2.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDLZ advanced for three days, in 166 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.

MDLZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. MDLZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDLZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.

The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.964) is normal, around the industry mean (1.261). P/E Ratio (22.662) is within average values for comparable stocks, (14.076). Projected Growth (PEG Ratio) (0.891) is also within normal values, averaging (1.364). Dividend Yield (0.034) settles around the average of (0.167) among similar stocks. P/S Ratio (2.028) is also within normal values, averaging (1.937).